"Breakthrough Antibiotic Emerges to Combat Superbugs with Unprecedented Resistance-Fighting Method"

Researchers have developed a new antibiotic called Zosurabalpin, which shows promise in treating drug-resistant Acinetobacter baumannii, a deadly bacteria responsible for serious infections and high mortality rates. This novel antibiotic, which is now in phase 1 clinical trials, operates by disrupting the bacteria's outer membrane, a method that could potentially be applied to other resistant Gram-negative bacteria. The breakthrough comes after a 50-year gap since the last class of antibiotics was approved to combat such pathogens, offering hope in the global fight against antimicrobial resistance.